Evidence map›Paper›PMID 26173456›Full record

ArticleHuman molecular genetics2015

Homozygous loss-of-function variants in European cosmopolitan and isolate populations.

Vera B Kaiser, Victoria Svinti, James G Prendergast, You-Ying Chau, Archie Campbell, Inga Patarcic, Inês Barroso, Peter K Joshi, Nicholas D Hastie, Ana Miljkovic and 21 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Emerging significance of butyrylcholinesterase.World journal of experimental medicine · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 8 institutions in 4 countries.

Vera B KaiserMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and vera.kaiser@igmm.ed.ac.uk.
Victoria SvintiMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
James G PrendergastThe Roslin Institute, The University of Edinburgh, Easter Bush, Midlothian EH25 9RG, UK.
You-Ying ChauMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
Archie CampbellCentre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK.
Inga PatarcicMedical School, University of Split, Soltanska 2, Split 21000, Croatia.
Inês BarrosoWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Peter K JoshiUsher Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK.
Nicholas D HastieMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
Ana MiljkovicMedical School, University of Split, Soltanska 2, Split 21000, Croatia.
Martin S TaylorMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
Generation Scotland
UK10K
Stefan EnrothDepartment of Immunology, Genetics, and Pathology, Biomedical Center, SciLifeLab Uppsala, Uppsala University, Uppsala SE-75108, Sweden and.
Yasin MemariWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Anja Kolb-KokocinskiWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Alan F WrightMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
Ulf GyllenstenDepartment of Immunology, Genetics, and Pathology, Biomedical Center, SciLifeLab Uppsala, Uppsala University, Uppsala SE-75108, Sweden and.
Richard DurbinWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Igor RudanUsher Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK.
Harry CampbellUsher Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK.
Ozren PolašekMedical School, University of Split, Soltanska 2, Split 21000, Croatia, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK.
Åsa JohanssonDepartment of Immunology, Genetics, and Pathology, Biomedical Center, SciLifeLab Uppsala, Uppsala University, Uppsala SE-75108, Sweden and.
Sascha SauerMax-Planck-Institute for Molecular Genetics, Otto-Warburg-Laboratory, Berlin, Germany.
David J PorteousCentre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK.
Ross M FraserUsher Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK.
Camilla DrakeMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
Veronique VitartMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
Caroline HaywardMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
Colin A SempleMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and.
James F WilsonMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine and Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK.
Institute of Genetics and Cancer · GBUppsala University · SEWellcome Sanger Institute · GBUniversity of Split · HRMax Planck Institute for Molecular Genetics · DEWestern General Hospital · GBRoslin Institute · GBUniversity of Edinburgh · GB

Funding

Chief Scientist Office CZB/4/276Chief Scientist Office CZB/4/438Chief Scientist Office CZB/4/710Chief Scientist Office CZD/16/6Chief Scientist Office CZD/16/6/4Medical Research Council G0900740Medical Research Council MC_PC_U127561128Medical Research Council MC_PC_U127597124Medical Research Council MR/K001744/1Wellcome Trust 100140Wellcome Trust WT091310
6 · The paper itself

Abstract

Homozygous loss of function (HLOF) variants provide a valuable window on gene function in humans, as well as an inventory of the human genes that are not essential for survival and reproduction. All humans carry at least a few HLOF variants, but the exact number of inactivated genes that can be tolerated is currently unknown—as are the phenotypic effects of losing function for most human genes. Here, we make use of 1432 whole exome sequences from five European populations to expand the catalogue of known human HLOF mutations; after stringent filtering of variants in our dataset, we identify a total of 173 HLOF mutations, 76 (44%) of which have not been observed previously. We find that population isolates are particularly well suited to surveys of novel HLOF genes because individuals in such populations carry extensive runs of homozygosity, which we show are enriched for novel, rare HLOF variants. Further, we make use of extensive phenotypic data to show that most HLOFs, ascertained in population-based samples, appear to have little detectable effect on the phenotype. On the contrary, we document several genes directly implicated in disease that seem to tolerate HLOF variants. Overall HLOF genes are enriched for olfactory receptor function and are expressed in testes more often than expected, consistent with reduced purifying selection and incipient pseudogenisation.

Indexed as

MutationExomeGene FrequencyHomozygoteHumansPhenotypeSelection, GeneticWhite People

Identifiers

PMID26173456
PMCPMC4572071
OpenAlexW2114617761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.